Open Account
Demo Account
About Us
Real-time Quotes & News
Market Analysis
Economic Calendar
Daily Market Analysis
Trading Platform
Platform Overview
How To Use
Terms
All Terms
Deposit & Withdrawal
Promotion
FAQ
Contact
繁
简
EN
User Login
Open Account
Demo Account
繁
简
EN
User Login
Open Account
Demo Account
About Us
About Aspire
Features of Aspire
Real-time Quotes & News
Real-time Quotes
Real-time News
Market Analysis
Economic Calendar
Market Analysis
Trading Platform
Meta Trader 5
Platform Features
Terms
All Terms
Deposit & Withdrawal
Promotion
FAQ
Contact
About Us
Terms
Metals Market
Trading Platform
Market Analysis
Promotion
FAQ
Contact
繁
简
EN
US President Trump: We will wait and see how things develop with the ceasefire with Iran.
2026-05-13
US President Trump: We will wait and see how things develop with the ceasefire with Iran.
Back
Other News
2026-05-12
Intel's market capitalization has surged by $440 billion in six weeks, drawing the attention of short sellers. According to foreign media reports, the rapid rise in Intel's stock price has resulted in huge losses for traders betting on its decline. H
Intel's market capitalization has surged by $440 billion in six weeks, drawing the attention of short sellers. According to foreign media reports, the rapid rise in Intel's stock price has resulted in huge losses for traders betting on its decline. However, this hasn't stopped them from continuing to place their bets. Since bottoming out on March 30, the chipmaker's stock price has soared 214%, adding over $440 billion to its market capitalization. According to data from financial data company S3 Partners, short sellers have also suffered paper losses exceeding $12 billion. Meanwhile, the ratio of short positions in Intel stock to outstanding shares (a measure of the number of shares borrowed to short the company) is near a 52-week high. Matthew Untman, Managing Director of S3 Partners, stated, "Intel is now almost a prime example of momentum trading. But this momentum will eventually stall."
2026-05-13
US President Trump: Kyle DiAmantas will succeed Macari as acting commissioner of the US Food and Drug Administration (FDA).
US President Trump: Kyle DiAmantas will succeed Macari as acting commissioner of the US Food and Drug Administration (FDA).
Chat with us
, powered by
LiveChat